 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Technology Platform
CG Therapeutics has proprietary platform technology that makes all human vaccines more potent by incorporating them in a new slow-release formulation.
|
|
|
|
|
|
||||||||||
|
|
|
|
||||||||||||
| The Potential To Improve Human Vaccines Worldwide | |
||||||||||||||
|
|
||||||||||||||
|
|
|
|||||||||||||
|
Technology Platform CG Therapeutics has proprietary platform technology that makes all human vaccines more potent by incorporating them in a new slow-release formulation. |
|
|
||||||||||||
|
|
||||||||||||||
|
© 2011 CG Therapeutics, Inc. | |
|||||||||||||